Fortis Healthcare Limited — Investor Meet, 10-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Fortis Healthcare reported its un-audited financial results for the quarter and half-year ended December 31, 2024. Key financial highlights include a revenue increase to ₹600 crore, a 25% improvement year-over-year, reflecting robust operational performance. The profit margin also showed a positive trend, with net profit rising to ₹80 crore, compared to ₹50 crore in the previous year. This yielded an earnings per share (EPS) of ₹4, up from ₹2.5.

Management expressed optimism about future growth, focusing on expanding services into new markets and enhancing patient care technologies. They cited a bullish outlook driven by increasing healthcare demand and strategic partnerships aimed at improving operational efficiencies.

The order book remains strong, with new contracts valued at ₹200 crore signed during the quarter, primarily in specialized care services. There is a commitment to advancing project timelines, especially in the rollout of new diagnostic facilities, expected to boost revenue further in upcoming quarters.

During the analyst Q&A, revenue and profitability were hot topics. Analysts sought clarity on sustainability of current growth rates, to which management reassured that operational efficiencies and market expansion would underpin continued profitability. Questions on competitive positioning revealed confidence about maintaining market share through quality care and innovation. Additionally, there were inquiries regarding supply chain challenges, which management acknowledged but expressed confidence in mitigating.

The overall strategic theme reflects strong commitment to innovation and expansion, making the company's future growth outlook positive, supporting a 'buy' position based on the financial health and growth potential observed.